Alzamend Neuro (ALZN) Net Preferred Shares Issued and Repurchased (2024)
Alzamend Neuro's Net Preferred Shares Issued and Repurchased was $5.13 million in fiscal Q2 2025 (quarter ended Oct 31, 2024), up 161.0% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Net Preferred Shares Issued and Repurchased (2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Pref. Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Alzamend Neuro | 6.61 Mn | 6.61 Mn | - | - |
API Access
Alzamend Neuro Net Preferred Shares Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-preferred-shares-issued-and-repurchased", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();